Maravai LifeSciences Holdings, Inc. MRVI Payments For Tax Receivable Agreement
Payments For Tax Receivable Agreement at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept mrvi:PaymentsForTaxReceivableAgreement.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s payments for tax receivable agreement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s payments for tax receivable agreement?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported payments for tax receivable agreement of $0 in Q4 2025.
- How has Maravai LifeSciences Holdings, Inc.'s payments for tax receivable agreement changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s payments for tax receivable agreement decreased by 100.0% year-over-year, from $1.78M to $0.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s payments for tax receivable agreement?
- Over 2 years (2023 to 2025), Maravai LifeSciences Holdings, Inc.'s payments for tax receivable agreement has grown at a -100.0% compound annual growth rate (CAGR), from $42.15M to $0.
- What does payments for tax receivable agreement mean?
- This metric tracks the actual cash payments made to satisfy obligations under a Tax Receivable Agreement. These payments represent the distribution of realized tax savings to pre-IPO shareholders or other beneficiaries. It is a key indicator of the long-term cash burden created by the company's historical tax structure.